ORIGINAL PUBLICATIONS
Liu XD, Conner H, Kobayashi T, Kim HJ, Wen FQ, Abe S, Fang QH,
Wang XQ, Hashimoto M, Bitterman P, Rennard SI. Cigarette smoke extract
induces DNA damage but not apoptosis in human bronchial epithelial
cells. Am J Respir Cell Molec Biol, 2005; 33:121-129.
Hatsukami DK, Rennard S, Jorenby D, Fiore M, Koopmeiners J, de Vos A,
Horwith G, Pentel PR. Safety and immunogenicity of a nicotine conjugate
vaccine in current smokers. Clin Pharmacol Therapeutics 2005;
78:456-467.
Freeman TL, Haver A, Duryee MJ, Tuma DJ, Klassen LW, Hamel FG, White RL,
Rennard SI, Thiele GM. Aldehydes incigarette smoke react with the lipid
peroxidation product malonaldehyde to form fluorescent protein adducts
on lysines, Chem Res Toxicol, 2005; 18:817-824.
Kato
J, Kohyama T, Okazaki H, Desaki M, Nagase T, Rennard SI, Takizawa H.
Leukotriene D(4) potentiates fibronectin-induced migration of human lung
fibroblasts. Clin Immunol 2005; 117:177-181.
Rennard SI. Understanding inflammation in obstructive lung disease. J
COPD 2005; 6:4-10.
Barr
RG, Celli BR, Martinez FJ, Ries A, Rennard S, Reilly J, Sciurba FC,
Thomashow B, Wise RA for the COPD Resource Network. Physician and
patient perceptions in COPD: Results of the COPD Resource Network Needs
Assessment Survey. Am J Med 2005; 118:1415.e9-1415.e17.
Celli
BR, Calverley PMA, Rennard SI, Wouters EFM, Agusti A, Anthonisen N,
MacNee W, Jones P, Pride N, Rodriguez-Roisin R, Rossi A, Wanner A.
Proposal for a multidimensional staging system for chronic obstructive
pulmonary disease. Respir Med 2005; 99:1546-1554.
Kobayashi T, Liu X, Wen FQ, Fang Q, Abe S, Wang XQ, Hashimoto M, Shen L,
Kawasaki S, Kim HJ, Kohyama T, Rennard SI. Smad3
mediates TGF-b1
induction of VEGF production in lung fibroblasts. Biochem Biophys Res
Commun 2005; 327:393-398.
Hatsukami DK, Rennard S, Patel MK, Kotlyar M, Malcolm R, Nides MA,
Dozier G, Bars MP, Jamerson BD. Effects of sustained-release bupropion
among persons interested in reducing by not quitting smoking. Am J Med
2004; 116:151-157.
Kim
H, Liu X, Kohyama T, Kobayashi T, Conner H, Abe S, Fang Q, Wen F-Q,
Rennard, SI. Cigarette smoke stimulates MMP-1 production by human lung
fibroblasts through the ERK1/2 pathway. Journal of COPD 2004; 1:13-23.
Wen
FQ, Liu X, Kobayashi T, Abe S, Fang Q, Kohyama T, Ertl R, Terasaki Y,
Manouilova L, Rennard SI. IFN-g
inhibits TGF-
production in human airway epithelial cells by targeting Smads. Am J
Respir Cell Molec Biol 2004; 30:816-822.
Kohyama T, Liu X, Wen FQ, Kobayashi T, Fang Q, Abe S, Cieslinski L,
Barnette MS, Rennard SI. Cytokines modulate
cilomilast response in lung fibroblasts. Clin Immunol 2004; 111:297-302.
Kim
H, Liu X, Kobayashi T, Conner H, Kohyama T, Wen FQ, Fang Q, Abe S,
Bitterman P, Rennard SI. Reversible cigarette smoke extract-induced DNA
damage in human lung fibroblasts. Am J Respir Cell Molec Biol 2004;
31:483-490.
Abe
S, Boyer C, Liu X, Wen FQ, Kobayashi T, Fang Q, Wang X, Hashimoto M,
Sharp JG, Rennard SI. Cells derived from the circulation contribute to
the repair of lung injury. Am J Respir Crit Care Med 2004;
170:1158-1163.
Fang
Q, Liu X, Abe S, Kobayashi T, Wang KQ, Kohyama T, Hashimoto M, Wyatt T,
Rennard SI. Thrombin induces collagen gel contraction partially through
PAR1 activation and PKC-.
Eur Respir J 2004; 24:918-924.
Watson L, Vestbo J, Postma DS, Decramer M, Rennard S, Kiri VA, Vermeire
PA, Soriano JB. Gender differences in the management and experience of
chronic obstructive pulmonary disease. Respir Med 2004; 998:1207-1213.
Pauwels R,
Calverley P, Buist AS, Rennard S, Fukuchi Y, Stahl E, Lofdahl CG. COPD
exacerbations:
the importance of
a standard definition. Respir Med 2004; 98:99-107.
Kohyama T, Liu X, Wen FQ, Kobayashi T, Abe S, Rennard SI. IL-4 and
IL-13 induce chemotaxis of human foreskin fibroblasts, but not human
fetal lung fibroblasts. Inflammation 2004; 28:33-37.
Fredriksson K, Stridh H, Lundahl J, Rennard SI
and Skold CM. Red blood cells inhibit proliferation and stimulate
apoptosis in human lung fibroblasts in vitro. Scand J Immunol, 2004;
59:559-65.
Calverley P, Rennard S. Application of management guidelines to the
assessment of new medicines: driving us forward or holding us back?
Eur Respir J, 2004; 23:793-794.
Ohta
K, Fukuchi Y, Grouse L, Mizutani R, Rabe KF, Rennard SI, Zhong, N-S. A
Prospective clinical survey of theophylline safety in 3,810 elderly
patients with asthma or COPD. Respir Med, 2004; 98:1016-1024.
Wang
H, Liu X, Umino T, Kohyama T, Zhu YK, Wen FQ, Spurzem JR, Romberger DJ,
Kim HJ, Rennard SI. Effect of cigarette smoke on fibroblast-mediated
gel contraction is dependent on cell density. Am J Phys 2003;
283:L205-L213.
Wen FQ,
Liu X, Manda W, Terasaki Y, Kobayashi T, Abe S, Fang Q, Ertl R,
Manouilova L, Rennard SI. The cytokine- and TGF-b-enhanced
vascular endothelial growth factor production by cultured human airway
smooth muscle cells is attenuated by interferon-gamma and
corticosteroids. J Allergy Clin Immunol 2003; 111:1307-1318.
Carnevali S, Mio T, Adachi Y, Spurzem JR, Striz I, Romberger DJ, Illig
M, Rennard, SI. Gamma radiation inhibits fibroblast-mediated collagen
gel retraction. Tissue & Cell 2003; 35:459-469.
Abe
S, Lauby G, Boyer C, Rennard SI, Sharp JG. Transplanted BM and BM side
population cells contribute progeny to the lung and liver in irradiated
mice. Cytotherapy 2003; 5:523-533.
Liu X, Wen FQ, Kobayashi T, Abe S, Fang Q,
Piek E, Bottinger EP, Roberts AB, Rennard SI. Smad3 mediates the TGF-b-induced
contraction of type I collagen gels by mouse embryo fibroblasts. Cell
Motility and the Cytoskeleton 2003; 54:248-253.
Hughes JR, Callas PW, High Dose Study
Group. Past alcohol problems do not predict worse smoking cessation
outcomes. Drug and Alcohol Dependence 2003; 71:269-273.
Wang H, Liu X, Umino T, Kohyama T, Zhu YK,
Wen FQ, Spurzem JR, Romberger DJ, Kim HJ, Rennard SI. Effect of
cigarette smoke on fibroblast-mediated gel contraction is dependent on
cell density. Am J Phys 2003; 283:L205-L213.
Wang HJ, Liu XD, Umino T, Sköld CM, Zhu YK,
Kohyama T, Spurzem JR, Romberger DJ, Rennard SI. Cigarette smoke
inhibits human bronchial epithelial cell repair processes. Am J Respir
Cell Molec Biol 2002; 25:772-779.
Rennard SI, Umino T, Millatmal T, Daughton
DM, Manouilova LS, Ullrich FA, Patil KD, Romberger DJ, Floreani AA,
Anderson JR. Evaluation of subclinical respiratory tract inflammation in
heavy smokers who switch to a cigarette-like nicotine delivery device
which primarily heats tobacco. Nicotine & Tobacco Research 2002;
4:467-476.
Fredriksson K, Lundahl J, Fernvik E,
Eklund A, Liu XD, Rennard SI, Sköld CM. Red blood cells stimulate
fibroblast-mediated contraction of three dimensional collagen gels in
co-culture. Inflammation Res 2002; 51:245-251.
Kohyama T, Liu X, Wen FQ, Zhu YK, Wang HJ,
Kim HJ, Takizawa H, Cieslinski LB, Barnette MS, Rennard SI. PDE4
inhibitors attenuate fibroblast chemotaxis and contraction of native
collagen gels: Potential anti-fibrotic effect. Am J Respir Cell Molec
Biol 2002; 26:694-701.
Kohyama T, Liu, X, Kim HJ, Kobayashi T,
Ertl RF, Wen FQ, Takizawa H, Rennard SI. Prostacyclin analogs inhibit
fibroblast migration. Am J Phys 2002; 283:L428-L432
Spurzem JR, Gupta J, Veys T, Kneifl KR,
Rennard SI, Wyatt TA. Activation of protein kinase A accelerates bovine
bronchial epithelial cell migration. Am J Physiol Lung Cell Mol Physiol
2002; 282:L1108-L1116.
Kohyama T, Wyatt TA, Liu X, Wen FQ,
Kobayashi T, Fang Q, Kim HJ, Rennard SI. PGD2 modulates
fibroblast-mediated native collagen gel contraction. Am J Respir Cell
Molec Biol 2002; 27:375-381.
Kohyama T, Liu X, Wen FQ, Kobayashi T, Abe S, Ertl Rennard SI. Nerve
growth factor stimulates fibronectin-induced fibroblast migration. J Lab
Clin Med 2002; 140:329-335.
Kohyama T, Liu X, Zhu YK, Wen FQ, Wang H, Fang Q, Kobayashi T, Rennard
SI. Phosphodiesterase4 inhibitor cilomilast inhibits
fibroblast-mediated collagen gel degradation induced by TNF- neutrophil
elastase. Am J Respir Cell Molec Biol 2002; 27:487-494.
Rennard S, Decramer M, Calverley PM, Pride NB, Soriano JB, Vermeire PA,
Vestbo J. The impact of COPD in North America and Europe in 2000: The
patients’ perspective of the Confronting COPD International Survey. Eur
Resp J 2002; 20:799-805.
Liu
X, Kohyama T, Wang H, Zhu YK, Wen FQ, Kim HJ, Romberger DJ, Rennard SI.
Th2 cytokine regulation of type I collagen gel contraction mediated by
human lung mesenchymal cells. Am J Physiology Lung Cell Mol Physiology
2002; 282:L1049-L1056.
Wen FQ,
Kohyama T, Sköld CM, Zhu YK, Liu X, Romberger DJ, Stoner J, Rennard SI.
Glucocorticoids modulate TGF-ß production. Inflammation 2002;
26:279-290.
Kohyama T, Liu X, Wen FQ, Kim HJ, Takizawa H, Rennard SI. Potentiation
of human lung fibroblast chemotaxis by the thromboxane A2
analog U-46619. J Lab Clin Med 2002; 139:43-49.
Mio T,
Liu X, Toews ML, Rennard SI. Lysophosphatidic acid augments
fibroblast-mediated contraction of released collagen gels J Lab Clin Med
2002; 139:20-27.
Wen FQ,
Kohyama T, Liu, X, Zhu YK, Wang H, Kim HJ, Kobayashi T, Abe S, Spurzem
JR, Rennard SI. IL-4 and IL-13 enhanced TGF-b2
production in cultured human bronchial epithelial cells is attenuated by
IFN-.
Am J Respir Cell Molec Biol 2002; 26:484-490.
Kohyama T, Liu XD, Wen FQ, Kim HJ, Takizawa H, Rennard SI.
Prostaglandin D2 inhibits fibroblast migration. Eur Resp J 2002;
19:684-689.
Kohyama T, Liu X, Wen FQ, Zhu YK, Wang HJ, Kim HJ, Takizawa H,
Cieslinski LB, Barnette MS, Rennard SI. PDE4 inhibitors attenuate
fibroblast chemotaxis and contraction of native collagen gels:
Potential anti-fibrotic effect. Am J Respir Cell Molec Biol 2002;
26:694-701.
Spurzem JR, Gupta J, Veys T, Kneifl KR, Rennard SI, Wyatt TA.
Activation of protein kinase A accelerates bovine bronchial epithelial
cell migration. Am J Physiol Lung Cell Mol Physiol 2002;
282:L1108-L1116.
Kohyama T, Liu X, Zhu YK, Wen FQ, Wang H, Fang Q, Kobayashi T, Rennard
SI. Phosphodiesterase4 inhibitor cilomilast inhibits
fibroblast-mediated collagen gel degradation induced by TNF-a
neutrophil elastase. Am J
Respir Cell Molec Biol 2002; 27:1-8.
Rennard SI, Anderson W, ZuWallack R, Broughton J, Bailey W, Friedman M,
Wisniewski M, Rickard K. The use of a long-acting inhaled
b2-adrenergic
agonist, salmeterol xinafoate, in patients with COPD. Am J Respir Crit
Care 2001; 163:1087-1092.
Wen
F-Q, Sköld CM, Liu X, Ertl RF, Zhu YK, Kohyama T, Wang H, Rennard SI.
Glucocorticoids and TGF-b1
synergize in augmenting fibroblast mediated contraction of collagen
gels. Inflammation 2001; 25:109-117
Zhu YK,
Umino T, Liu XD, Wang HJ, Romberger DJ, Spurzem JR, Rennard SI.
Contraction of fibroblast containing collagen gels: Initial collagen
concentration regulates the degree of contraction and cell survival. In
Vitro Cell Dev Biol - Animal 2001; 37:10-16
Polosukhin VV, Manouilova LS, Romberger DJ, Matthews KI, Pirruccello SJ,
West W, Daughton DM, Millatmal T, Umino T, Rennard SI. Ultrastructural
heterogeneity of the alveolar macrophages from tobacco smokers with
chronic bronchitis. Ultrastructural Pathology 2001; 25:5-11.
Liu
XD, Zhu YK, Umino T, Spurzem, Romberger DJ, Wang H, Reed E, Rennard SI.
Cigarette smoke inhibits osteogenic differentiation and proliferation of
human osteoprogenitor in monolayer and three dimensional collagen gel
culture. J Lab Clin Med 2001; 137:208-219
Casale
GP, Singhal M, Bhattacharya S, RamaNathan R, Roberts KP, Zhao J,
Jankowiak R, Gross ML, Cavalieri EL, Small GJ, Rennard SI, Mumford JL,
Shen M. Detection and quantification of dupurinated benzo[a]pyrene-adducted
DNA bases in the urine of cigarette smokers and women exposed to
household coal smoke. Chem Res in Toxicol 2001; 14:192-201.
Rennard SI, Anderson W, ZuWallack R, Broughton J, Bailey W, Friedman M,
Wisniewski M, Rickard K. The use of a long-acting inhaled
b2-adrenergic
agonist, salmeterol xinafoate, in patients with COPD. Am J Respir Crit
Care 2001; 163:1087-1092.
Liu
XD, Umino T, Ertl R, Veys T, Sköld CM, Takigawa K, Romberger DJ, Spurzem
JR, Zhu YK, Kohyama T, Wang H, Rennard SI. Persistence of TGF-b1
induction of increased fibroblast contractility. In Vitro 2001;
37:193-201.
Mio T,
Liu X, Toews ML, Adachi A, Romberger DJ, Spurzem JR, Rennard SI.
Bradykinin augments fibroblast mediated contraction of released collagen
gels. Am J Phys 2001; 281:L164-L171.
Sköld
CM, Ohkuni Y, Liu XD, Numerof R, Rennard SI. Co-cultured human mast
cells stimulate fibroblast-mediated contraction of collagen gels.
Inflammation 2001; 25:47-51.
Zhu YK,
Liu XD, Sköld CM, Umino T, Wang HJ, Spurzem JR, Kohyama T, Ertl RF,
Rennard SI. Synergistic neutrophil elastase cytokine interaction leads
to collagen degradation in three-dimensional collagen gel culture. Am J
Physiol Lung Cell Mol 2001; 281:L868-L878.
Zhu YK,
Liu X-D, Sköld CM, Umino T, Wang H, Romberger DJ, Spurzem JR, Kohyama T,
Wyatt T, Wen FQ, Rennard SI. Cytokine inhibition of fibroblast induced
gel contraction is mediated by PGE2 and NO acting through
separate parallel pathways. Am J Respir Cell Molec Biol 2001:25:245-253
Zhu YK,
Liu XD, Ertl RF, Kohyama T, Wen FQ, Wang H, Spurzem JR, Romberger DJ,
Rennard SI. Retinoic acid attenuates cytokine-driven fibroblast
degradation of extracellular matrix in three-dimensional culture. Am J
Respir Cell Molec Biol 2001; 25:620-627.
Zhu YK,
Sköld CM, Liu XD, Wang, H, Kohyama T, Wen FQ, Ertl RF, Rennard SI.
Fibroblasts and monocyte macrophages contract and degrade
three-dimensional collagen gels in extended co-culture. Respir Res
2001; 2:295-299.
Zhu YK,
Liu XD, Sköld CM, Wang H, Kohyama T, Wen FQ, Ertl RF, Rennard SI.
Collaborative interactions between neutrophil elastase and
metalloproteinases in extracellular matrix degradation in
three-dimensional collagen gels. Respir Res 2001; 2:300-305.
Kohyama T, Ertl RF, Valenti V, Spurzem J, Kawamoto M, Nakamura Y, Veys
T, Allegra L, Romberger D, Rennard SI. Prostaglandin E2
inhibits fibroblast chemotaxis. Am J Phys 2001; 281:L1257-L1263.
Jamerson BD, Nides M, Jorenby DE, Donahue R, Garrett P, Johnston JA,
Fiore MC, Rennard SI, Leischow SJ. Late-term smoking despite initial
failure: An evaluation of bupropion sustained release, nicotine patch,
combination therapy, and placebo. Clinical Therapeutics 2001;
23:744-752.
Zhu Y,
Liu XD, Wang HJ, Kohyama T, Wen FQ, Sköld CM, Rennard SI. Interactions
between monocytes and smooth muscle cells can lead to extracellular
matrix degradation. J Allergy Clin Immunol 2001; 108:989-996.
Liu
XD, Zhu YK, Umino T, Spurzem, Romberger DJ, Wang H, Reed E, Rennard SI.
Cigarette smoke inhibits osteogenic differentiation and proliferation of
human osteoprogenitor in monolayer and three dimensional collagen gel
culture. J Lab Clin Med 2001; 137:208-219.
Rennard SI,
Schachter N, Streck M, Rickard K, Amit O. Cilomilast for COPD:
results of a six month, placebo-controlled study of a potent, selective
inhibitor of phosphodiesterase 4. Chest 2006; 129:56-66.
REVIEWS,
BOOK CHAPTERS, EDITORIALS AND CORRESPONDENCE
Rennard SI. Minimal clinically important difference, clinical
perspective: An opinion. COPD; J of Chronic Obstructive Pulmonary
Disease 2005; 2:51-55
Spurzem JR,
Rennard SI. Pathogenesis of COPD. Semin Respir Crit Care Med, 2005;
26:142-153.
Rennard SI.
Minimal clinically important difference, clinical perspective: an
opinion. COPD: J COPD 2005; 2:51-55.
Rennard SI.
Combination therapy with bronchodilators. In: Therapeutic Strategies
in COPD. M Cazzola, B Celli, R Dahl, S Rennard (eds). Clinical
Publishing, Oxford, UK, 2005, pp. 137-149.
Rennard
SI. Treatment of stable chronic obstructive pulmonary disease. Lancet
2004; 364:791-80.
Rennard SI. Introduction. The symposium that never occurred:
pre-clinical and clinical development of sibenadet. Resp Med 2003;
97:S1-2.
Rennard SI. Pathogenesis of COPD. Clinical Cornerstone 2003; 5:11-16.
Manda
W, Rennard SI. Taking pharmacologic management of COPD into the future.
J Crit Illness 2003; 18:33-42.
Rennard SI. Repair. In: Chronic Obstructive Pulmonary Disease. PMA
Calverley, W MacNee, NB Pride, SI Rennard (eds), Arnold, London, 2003,
pp 139-150.
Rennard SI, Daughton DM. Smoking cessation. In: Chronic Obstructive
Pulmonary Disease. PMA Calverley, W MacNee, NB Pride, SI Rennard (eds),
Arnold, London, 2003, pp 327-340.
Rennard SI. COPD: treatments benefit patients. Lancet 2003;
361:44-445.
Piquette CA, Rennard SI. Assessment of severity of acute exacerbation
of chronic obstructive pulmonary disease. In: Acute Exacerbation of
Chronic Obstructive Pulmonary Disease, N. Siafakas (ed), Marcel Dekker,
New York 2003; pp 203-227.
Toews
ML, Ediger TL, Romberger DJ, Rennard SI. Lysophosphatidic acid in
airway function and disease. Biochim Biophys Acta 2002; 1582:240-250.
Rennard SI. New therapeutic drugs in the management of COPD. Curr Opin
Pulm Med 2002; 8:106-111.
Rennard SI. Treatment for stable COPD. In: Asthma and COPD, P. Barnes,
J. Drazen, S. Rennard, N. Thomson (eds), Academic Press, Amsterdam,
2002, 713-726.
Rennard SI, Barnes PJ. Pathogenesis of COPD. In: Asthma and COPD, P.
Barnes, J. Drazen, S. Rennard, N. Thomson (eds), Academic Press,
Amsterdam, 2002, 361-379.
Spurzem JR, Rennard SI. Epithelial cells. In: Asthma and COPD, P.
Barnes, J. Drazen, S. Rennard, N. Thomson (eds), Academic Press,
Amsterdam, 2002, 145-154.
Spurzem, J, Zhang J, Liu XD, Rennard SI, Romberger DJ. Gene expression
in an in vitro model of epithelial repair. Chest 2002; 121:79S-80S.
Manda
W, Rennard SI. COPD in older adults, Part 1: Prevalence, risk factors
and diagnosis. Geriatric Times 2002; 3:36-39.
Rennard SI. Overview of causes of COPD. Postgraduate Med 2002;
111:28-38.
Manda
W, Rennard SI. COPD in older adults, Part II: Treatment strategies.
Geriatric Times 2002; 3:39-41.
Fabbri L, Rennard
S, Leff A, O’Connor B. Advances in the understanding and future therapy
of COPD. Clin Exp All Rev 2002; 2:129-136.
Daughton DM, Rennard SI. Practice-based smoking cessation
interventions. Eur Respir Rev 2002; 12:432-435.
Rennard SI, Farmer SG. COPD in 2001. A major challenge for medicine,
the pharmaceutical industry and society. Chest 2002; 151:113S-115S.
Rennard SI, Atwood J, Daughton DM. Organisation of smoking cessation
programmes: the future. Eur Respir Rev 2002; 12:436-438.
Rennard SI. New understanding of the pathogenesis and mechanisms of
COPD. Postgraduate Medicine 2002; 111:28-30, 33-34, 37-38.
Johnson M, Rennard S. Alternative mechanisms for long-acting
b2-adrenergic
agonists in COPD. Chest 2001; 120:258-270.
Rennard SI. Epithelial cells and fibroblasts. In: Chronic Obstructive
Pulmonary Disease: Pathogenesis to Treatment. Novartis Foundation
Symposium. John Wiley & Sons, United Kingdom. 2001. pp.104-119.
Lieberman P, Calhoun WJ, Panettieri RA, Peters SP, Rennard SI. Asthma
and irreversible lung disease: Remodeling - fact or fiction? Medical
Crossfire 2001; 3:31-43.
Tran
V, Rennard SI. Lack of response to initial
b-agonist
therapy for acute COPD: What to do? J Crit Illness 2001; 16:114-117.
Rennard SI, Daughton DM. Sevrage tabagique: le rôle du bupropion. La
Lettre du Pneumologue 2001; 3:95-134.
Pauwels RA, Buist S, Calverley MA, Jenkins CR, Hurd SS on behalf of the
GOLD Scientific Committee. Global strategy for the diagnosis,
management and prevention of chronic obstructive pulmonary disease. Am
J Respir Crit Care Med 2001; 163:1256-1276.
Rennard SI, Daughton DM. Smoking cessation. In: Chronic Obstructive
Lung Disease, N.F. Voelkel, W. MacNee (eds), B.C. Decker, Inc.,
Hamilton, 2001, pp. 332-340.
Spurzem JR, Rennard SI. The airway
epithelium. In: Chronic Obstructive Lung Disease, N.F. Voelkel, W.
MacNee (eds), B.C. Decker, Inc., Hamilton, 2001, pp. 21-40.
Back to Top